2m 2m 2m 2m 2m 2m 2m
Telesis Bio (TBIO)
OTC
$3.75+$3.70 (+6,975.47%)
Price as of Oct 01, 2024 11:52 AM EDT- $6.8MMarket Cap
- 6.00%1-Year Change
- Medical DevicesIndustry
Telesis Bio (TBIO)
$3.75+$3.70 (+6,975.47%)
TBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.05 | ||
Change | +$0.05 (+5,200.00%) | ||
Open | $0.05 | ||
High | $0.05 | ||
Low | $0.05 | ||
Previous Close | $0.00 | ||
Volume | 851 | ||
30-Day Average Volume | 412 | ||
1-Week Change | 5,200.00% | ||
1-Month Change | 3.92% | ||
1-Year Change | 6.00% | ||
3-Year Change | -99.84% | ||
5-Year Change | -99.98% | ||
Fundamentals | |||
Shares Outstanding | 1.8M | ||
Total Assets | $52.7M | ||
Market Cap | $6.8M | ||
Enterprise Value | $5.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$12.6M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$12.4M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $7.1M | ||
EPS | -$7.62 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 4 | ||
P/B | -0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 05/09/2024 | ||